X-ray Structural Analysis of Carbonic Anhydrase and Carborane-Based
Inhibitors Complexes
Jiří Brynda1,2, Pavel Mader1,2, Václav
Šícha3, Milan Fábry1, Bohumír
Grüner3, Petr Cígler2, Pavlína Řezáčová1,2
1Institute of
Molecular Genetics Academy of Sciences of the Czech Republic, v.v.i.
2Institute of
Organic Chemistry and Biochemistry AS CR, v.v.i.
3Institute of Inorganic Chemistry, Academy of Sciences of the
Czech Republic, v.v.i.
Human
carbonic anhydrases (CA) are zinc metalloenzymes
that play an important role in many physiological processes. To date, 15 human
CA isozymes have been identified. Many
experimental evidence also
suggests involvement of CAs in various pathological processes, e.g. tumorigenicity, thus, many CA isozymes
are recognized as diagnostic and therapeutic targets. About 30 CA inhibitors
are used clinically as drugs. The traditional CA inhibitors
contain a sulfonamide or sulfamide moiety that
coordinates the zinc cation located in the CA
catalytic site. Although the conical active site clefts of different human CA isoezymes are conserved, variations in aminoacid
residues exist at the entrance to the active site. These surface pockets with
different shape and hydrophobicity can be exploited
to design specific inhibitors. With the help of manual molecular docking into
the active site of CAII, we designed new molecule, which contains a sulfamide group connected to a carborane
cluster intended to optimally fill the enzyme active site entry.